List view / Grid view
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow is the only company in the world able to provide a complete package of fluid path technology expertise to the biotechnology industries...
27 April 2016 | By Watson-Marlow Fluid Technology Group
Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow Fluid Technology Group has introduced its new 530 peristaltic cased pump for upstream and downstream bioprocessing tasks...
27 April 2016 | By Victoria White, Digital Content Producer
Researchers at are using so-called "machine learning" technologies to predict whether patients will participate in clinical trials...
27 April 2016 | By Victoria White, Digital Content Producer
The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure.
27 April 2016 | By Victoria White, Digital Content Producer
The decision from the EC was based on data from the international, double-blind, placebo-controlled Phase III RECOURSE study...
27 April 2016 | By Victoria White, Digital Content Producer
The guidance recommends paclitaxel and PLDH for treating ovarian cancer that has returned after previous chemotherapy treatment...
26 April 2016 | By Victoria White, Digital Content Producer
Norovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...
26 April 2016 | By Victoria White, Digital Content Producer
Alizé Pharma has announced top-line results of a Phase II clinical trial of AZP-531 in patients with Prader-Willi Syndrome (PWS)...
26 April 2016 | By Victoria White, Digital Content Producer
The EC has granted marketing authorisation for Lilly’s ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults...
26 April 2016 | By Victoria White, Digital Content Producer
Under the terms of the agreement, Ironwood Pharmaceuticals will acquire exclusive US rights to Zurampic from AstraZeneca...
26 April 2016 | By Victoria White, Digital Content Producer
Allergan has broken ground on a $200 million expansion of its Texas Waco facility that will nearly double its current footprint when completed...
When Enzymatic Therapy stopped outsourcing and built its own FDA-approved manufacturing facility, the goal was to improve product quality, streamline production, and ramp up sales growth. A crucial step was selecting the right pharmaceutical sieving equipment to remove any agglomerates, oversize particles or contaminants from incoming raw dry materials.
25 April 2016 | By Victoria White, Digital Content Producer
The designation is based on results of a Phase III trial evaluating Opdivo versus investigator’s choice of therapy in patients with SCCHN...
25 April 2016 | By Victoria White, Digital Content Producer
Descovy is the first new HIV backbone approved in Europe in more than a decade and represents an important advance in addressing the needs of patients...
